Contextualising cox-2 selective and non-selective NSAID risk - Providing a background for understanding risks of medical treatments

Contextualising cox-2 selective and non-selective NSAID risk - Providing a background for understanding risks of medical treatments

Detalles Bibliográficos
Main Authors:	Moore, A, Derry, S
Formato:	Conference item
Publicado:	2006

Títulos similares

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs.
por: Moore, R, et al.
Publicado: (2008)

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs
por: Moore, R, et al.
Publicado: (2008)

Calculating the balance of gastrointestinal and cardiovascular risk with combs and nsaids
por: Moore, A, et al.
Publicado: (2006)

Comparison Between Two NSAIDs (Non selective & selective COX-2 Inhibitor) According to their Renal Toxicity on Elderly People
por: Haydar F. Hadi
Publicado: (2007-06-01)

Gastric and renal effects of COX-2 selective and non-selective NSAIDs in rats receiving low-dose aspirin therapy
por: Marcella Goetz MORO, et al.

New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation
por: Riham M. Bokhtia, et al.
Publicado: (2023-02-01)

Gastrointestinal harm from NSAIDs: An operations research approach
por: Moore, A, et al.
Publicado: (2006)

Topical NSAIDs for chronic musculoskeletal pain in adults.
por: Derry, S, et al.
Publicado: (2012)

Topical NSAIDs for chronic musculoskeletal pain in adults.
por: Derry, S, et al.
Publicado: (2012)

Topical NSAIDs for acute pain in adults
por: Massey, T, et al.
Publicado: (2010)

Topical NSAIDs for acute pain in adults.
por: Massey, T, et al.
Publicado: (2010)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
por: Moore, R, et al.
Publicado: (2006)

Topical NSAIDS for chronic musculoskeletal pain in adults
por: Derry, S, et al.
Publicado: (2009)

Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors
por: U Klotz
Publicado: (2005-03-01)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
por: Alaa Rostom, et al.
Publicado: (2009-10-01)

Effects of the Highly COX-2-Selective Analgesic NSAID Etoricoxib on Human Periodontal Ligament Fibroblasts during Compressive Orthodontic Mechanical Strain
por: Christian Kirschneck, et al.
Publicado: (2019-01-01)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
por: Phillips Ceri J, et al.
Publicado: (2006-10-01)

Topical NSAIDs for acute pain: a meta-analysis
por: Mason, L, et al.
Publicado: (2004)

NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies.
por: Luis Alberto García Rodríguez, et al.
Publicado: (2011-02-01)

Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond
por: Praveen Rao, et al.
Publicado: (2008-09-01)

Faecal blood loss: Systematic review and analysis of randomised trials with aspirin and NSAIDs
por: Moore, A, et al.
Publicado: (2007)

Non-steroidal anti-inflammatory drugs(NSAIDs) and physiotherapy - a selective review
por: P. van der Bijl, et al.
Publicado: (2002-01-01)

Examining the Risks for NSAID-Induced Gastropathy
por: Sherine E Gabriel, et al.
Publicado: (1990-01-01)

Impact of NSAIDs on cardiovascular risk and hypertension
por: William B. White, et al.
Publicado: (2013-03-01)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris RE, et al.
Publicado: (2012-08-01)

Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis
por: Filippo Migliorini, et al.
Publicado: (2022-07-01)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
por: Straube, S, et al.
Publicado: (2009)

Exploring COX-Independent Pathways: A Novel Approach for Meloxicam and Other NSAIDs in Cancer and Cardiovascular Disease Treatment
por: Lixia Cheng, et al.
Publicado: (2024-11-01)

Topical NSAIDs for acute pain: a meta-analysis
por: Derry Sheena, et al.
Publicado: (2004-05-01)

Pharmacodynamic and Pharmacokinetic Comparison between Selective and Non-selective COX-2 Inhibitors in Mice
por: Taimaa Yahya, et al.
Publicado: (2024-04-01)

Select dietary phytochemicals function as inhibitors of COX-1 but not COX-2.
por: Haitao Li, et al.
Publicado: (2013-01-01)

Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk
por: Moore, R, et al.
Publicado: (2007)

Comparison of NSAIDs activity in COX-2 expressing and non-expressing 2D and 3D pancreatic cancer cell cultures
por: Čeponytė U, et al.
Publicado: (2018-06-01)

COX ARCHITECTS : Selected and Current Works /
por: Dobney, Stephen, editor 208043, et al.
Publicado: (1994)

Hartman-Cox : selected and current works /
por: 238867 Hartman, George E., et al.
Publicado: (1994)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
por: Derry Sheena, et al.
Publicado: (2009-06-01)

The Flux of Select NSAIDs through Silicone Membranes from Mineral Oil
por: Paul S. Mertz, et al.
Publicado: (2014-07-01)

Cardiovascular risk of NSAIDs: time to translate knowledge into practice.
por: K Srinath Reddy, et al.
Publicado: (2013-01-01)

Do NSAID/COX-2 Inhibitors Increase Nonunion After Fracture Surgery? Dilemma and Consideration In Use
por: Azmi
Publicado: (2022-10-01)

Rational Design and Synthesis of New Selective COX-2 Inhibitors with In Vivo PGE2-Lowering Activity by Tethering Benzenesulfonamide and 1,2,3-Triazole Pharmacophores to Some NSAIDs
por: Nada H. El-Dershaby, et al.
Publicado: (2022-09-01)